Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Avi Kapoor

Gilead, Coinbase, Rocket Lab And A Tech Stock On CNBC's 'Final Trades'

Close,Up,Of,Gilead,Sciences,Logo,And,Sign,On,The

On CNBC's “Halftime Report Final Trades,” Rob Sechan, CEO of NewEdge Wealth, named Gilead Sciences, Inc. (NASDAQ:GILD) as his final trade.

Lending support to his choice, Citigroup analyst Geoff Meacham maintained a Buy rating for Gilead Sciences on Oct. 8, raising the price target from $125 to $135.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.